Preparation and evaluation of poly (caprolactone fumarate) nanoparticles containing doxorubicin HC1

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 1, 2011, Pages 12-22

  Shokri, N ^a   Akbari Javar, H ^a,e   Sh, Fouladdel ^b   Khalaj, A ^a   Khoshayand, MR ^a   Dinarvand, R ^a,c   Atyabi, F ^a,c   Nomani, A ^d   Azizi, E ^b  

^a Department of pharmaceutics ^*  (Malaysia)

^b Molecular Research Lab   (Malaysia)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Copolymer molecular weight; Nanoprecipitation method; PCLF nanoparticles

Indexed keywords

DICHLOROMETHANE; DOXORUBICIN; NANOPARTICLE; ORGANIC SOLVENT; PHOSPHATE BUFFERED SALINE; POLY(CAPROLACTONE FUMARATE); POLYCAPROLACTONE; POLYVINYL ALCOHOL; SODIUM HYDROXIDE; SURFACTANT; TRYPAN BLUE; UNCLASSIFIED DRUG; WATER;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS LINKING; DEGRADATION; DRUG DELIVERY SYSTEM; MICROEMULSION; MOLECULAR IMAGING; MOLECULAR SIZE; MOLECULAR WEIGHT; NANOFABRICATION; NANOPHARMACEUTICS; PHOTOSTIMULATION; POLYMERIZATION; PRECIPITATION; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; SYNTHESIS; TIME;

EID: 79953286309     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin OR, Kim DD, Chung S J, Shim CK. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Int J Pharm. 2009; 371: 142-7.
2. Matsumura YMH. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumor tropic accumulation of proteins and antitumor agent SMANCS. Cancer Res. 1986; 46: 6387-92.
3. Kim SY, Ha JCH, Lee YM. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/ poly(caprolactone) (PCL) amphiphilic block copolymeric nanospheres: II. Thermo-responsive drug release behaviors. J. Cont. Rel. 2000; 65: 345-58.
4. Park JS, Woo DG, Sun BK, Chung HM, Im SJ, Choi YM, Park K, Huh KM, Park KH. In vitro and in vivo test of PEG/PCL-based hydrogel scaffold for cell delivery application. J. Cont. Rel. 2007; 124: 51-59.
5. Zhou SH, Deng X, Yang H. Biodegradable poly(caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. Biomaterials. 2003; 24:3563-3570.
6. Huatan HCJ, Attwood D. The microencapsulation of protein using a novel ternary blend based on poly (caprolactone). J. Microen. 1995; 12: 557-567.
7. Peng H, Ling J, Liu J, Zhu N, Ni X, Shen Zh. Controlled enzymatic degradation of poly(caprolactone)-based copolymers in the presence of porcine pancreatic lipase. Polym. Deg. Stab. 2010; 95: 643-650.
8. Wei X, Gong CY, Gou M, Fu SZ, Guo QF, Shi Sh, Luo F, Guo G, Qiu LY, Qian ZY Biodegradable poly(caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Int. J. Pharm. 2009; 381: 1-18.
9. Gou M, Zheng L, Peng XY, Men K, Zheng XL, Zeng Sh, Guo G, Luo F, Zhao X, Chen LJ, Wei YQ, Qian ZY. Poly(caprolactone)-poly(ethylene glycol)-poly(caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro. Int. J. Pharm. 2009; 375: 170-176.
10. Shin H, Ruhe PQ, Mikos AG, Jansen JA. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials. 2003; 24: 3201-3211.
11. Dirk W. Grijpma QH, Jan Feijen. Preparation of biodegradable networks by photo-crosslinking lactide, 8-caprolactone and trimethylene carbonate-based oligomers functionalized with fumaric acid monoethyl ester. Biomaterials. 2005; 26: 2795-2802.
12. Wang SH, Lu L, Gruetzmacher J, Currier B, Yaszemski M. Synthesis and characterizations of biodegradable and crosslinkable poly(e-caprolactone fumarate), poly(ethylene glycol fumarate), and their amphiphilic copolymer. Biomaterials. 2006; 27: 832-841.
13. Wang Sh, Yaszemski M, Knight A, Gruetzmacher J, Windebank A, Lu L. Photo-crosslinked poly(e-caprolactone fumarate) networks for guided peripheral nerve regeneration: Material properties and preliminary biological evaluations. Acta Biomaterialia. 2009; 5: 1531-1542.
14. Sou K, Inenaga Sh, Takeoka Sh, Tsuchida E. Loading of curcumin into macrophages using lipid-based nanoparticles. Int. J. Pharm. Pharmaceutical Nanotechnology. 2008; 352: 287-293.
15. Paliwal R, Rai Sh, Vaidya B, Khatri K, K. Goyal A, Mishra N, Mehta A, Vyas S. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomed. 2009; 5: 184-191.
16. Wang Sh, Yaszemski M, Gruetzmacher J, Lu L. Photocrosslinked poly(caprolactone fumarate) networks: Roles of crystallinity and crosslinking density in determining mechanical properties. Polym. 2008; 49: 5692-5699.
17. Missirlis D, Tirelli N, Hubbell J. Amphiphilic hydrogel nanoparticles. Preparation, characterization, and preliminary assessment as new colloidal drug carriers. Langmuir. 2005; 21: 2605-2613.
18. Akbari H, Emanuele A, Attwood D. Effect of geometry on the erosion characteristics of polyanhydride matrices. Int J Pharm. 1998; 160: 83-89.
19. Akbari H, Emanuele A, Attwood D. Effect of geometry on the erosion characteristics of polynhydride devices. Proceed Intern Symp Control Rel Bioact Mater. 1997; 24-30.
20. Peracchia MT FE, Desmaële D, Besnard M, Noël JP, Gomis JM, Appel M, Angelo J, Couvreur P. Stealth PE Gylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J. Cont. Rel. 1999; 60: 121-128.
21. Hakkarainen M, Albertsson AC. Heterogeneous biodégradation of poly-caprolactone-low molecular weight products and surface changes. Macromol Chem Phys. 2002; 203: 1357-1363.
22. Eldsater C, Erlandsson B, Renstad R, Albertsson AC, Karlsson S. The biodégradation of amorphous and crystalline regions in film-blown poly(caprolactone). Polym. 2000; 41: 1297-1304.
23. Abou-Zeid DM, Müller RJ, Deckwer WD. Biodegradation of aliphatic homopolyesters and aliphatic-aromatic copolyesters by anaerobic microorganisms. Biomacromolecules. 2004; 5: 1687-1697.
24. Harrison KL, Jenkins MJ. The effect of crystallinity and water absorption on the dynamic mechanical relaxation behaviour of polycaprolactone. Polym. Int. J. 2004; 53: 1298-1304.
25. Jenkins MJ, Harrison KL. The effect of molecular weight on the crystallization kinetics of polycaprolactone. Polym. Adv. Tech. 2006; 17: 474-478.
26. Bilati U, Allemann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur. J. Pharm. Sei. 2005; 24: 67-75.
27. Stainmesse S, Orecchioni AM, Nakache E. Modelling of an original process to obtain biocompatible polymeric nanospheres. Proc Sixth Congr Int Technol Pharm. 1992;39: 89-97.
28. Lamprecht A, Ubrich N, Hombreiro Perez M, Lehr CM, Hoffman M, Maincent P. Biodegradable monodispersed nanoparticles prepared by pressure homogenization emulsification. Int. J. Pharm. 1999: 184: 97-105.
29. Zhang J, Chen XG, Li YY, Liu CS. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomed. 2007; 3: 258-265.
30. Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres composed of methoxy poly (ethylene glycol) and poly (caprolactone) as novel anticancer drug carriers. Biomaterials. 2001; 22: 1697-1704.
31. Muller RH, ed. Colloidal carriers for controlled drug delivery and targeting modification, characterization and in vivo distribution. FL, CRC Press, 1991; 57-97.
32. El-Malah Y, Nazzal S. Hydrophilic matrices: Application of Placket-Burman screening design to model the effect of POLYOX-carbopol blends on drug release. Int. J. Pharm. 2006; 309: 163-170.